Unlock stock picks and a broker-level newsfeed that powers Wall Street.

XETRA - Delayed Quote EUR

Gerresheimer AG (GXI.DE)

60.55
+1.15
+(1.94%)
At close: May 2 at 5:35:25 PM GMT+2
Loading Chart for GXI.DE
  • Previous Close 59.40
  • Open 60.40
  • Bid 61.25 x 21100
  • Ask 61.35 x 8200
  • Day's Range 60.10 - 61.55
  • 52 Week Range 49.56 - 109.70
  • Volume 221,481
  • Avg. Volume 262,794
  • Market Cap (intraday) 2.091B
  • Beta (5Y Monthly) 0.95
  • PE Ratio (TTM) 26.56
  • EPS (TTM) 2.28
  • Earnings Date Jul 9, 2025 - Jul 14, 2025
  • Forward Dividend & Yield 1.25 (2.06%)
  • Ex-Dividend Date Jun 6, 2025
  • 1y Target Est 93.67

Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services. It also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, the company offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. It offers its products to pharmacy chains, supermarkets, and wholesalers. The company serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.

www.gerresheimer.com

13,632

Full Time Employees

November 30

Fiscal Year Ends

Recent News: GXI.DE

View More

Performance Overview: GXI.DE

Trailing total returns as of 5/2/2025, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .

YTD Return

GXI.DE
14.72%
DAX P (^GDAXI)
15.96%

1-Year Return

GXI.DE
39.70%
DAX P (^GDAXI)
29.00%

3-Year Return

GXI.DE
3.20%
DAX P (^GDAXI)
65.63%

5-Year Return

GXI.DE
10.93%
DAX P (^GDAXI)
112.55%

Compare To: GXI.DE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: GXI.DE

View More

Valuation Measures

As of 5/2/2025
  • Market Cap

    2.09B

  • Enterprise Value

    4.07B

  • Trailing P/E

    26.56

  • Forward P/E

    11.47

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.00

  • Price/Book (mrq)

    1.38

  • Enterprise Value/Revenue

    1.95

  • Enterprise Value/EBITDA

    9.95

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.77%

  • Return on Assets (ttm)

    3.01%

  • Return on Equity (ttm)

    5.42%

  • Revenue (ttm)

    2.09B

  • Net Income Avi to Common (ttm)

    78.7M

  • Diluted EPS (ttm)

    2.28

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    150.79M

  • Total Debt/Equity (mrq)

    148.29%

  • Levered Free Cash Flow (ttm)

    -666.52M

Research Analysis: GXI.DE

View More

People Also Watch